Essex Pharma Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Waltrop Germany (2008)
Status: Acquired by Nuvisan Pharma Services (2011)

Organization Overview

First Clinical Trial
2008
NCT00944801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Essex Pharma GmbH | Essex Pharma (Schering-Plough) Germany